Piramal Alts lends $22.5M to South India's Kolors Healthcare
What's the deal? Piramal AlternativesDealroom has a profile for this one. Try Dealroom → has invested 2.15 billion INR ($22.5 million) in debt into Kolors Healthcare IndiaDealroom has a profile for this one. Try Dealroom →, a Telangana-based health and wellness platform, the fund management arm of the Piramal GroupDealroom has a profile for this one. Try Dealroom → said on August 26. The capital came through its India Credit Opportunities Fund IIDealroom has a profile for this one. Try Dealroom →.
What's the endgame? Kolors runs a network of wellness centres offering weight management, skin care, hair care, and aesthetic treatments, pairing doctors, nutritionists, and physiotherapists with technology-enabled protocols. The company will use the money to expand its clinics, upgrade infrastructure, and broaden services under a "Kolors 2.0" overhaul.
By the numbers: Kolors posted consolidated revenue of 2.285 billion INR in fiscal 2024-25, up 22%, with net profit of 94 million INR, according to PrivateCircleDealroom has a profile for this one. Try Dealroom → data.
Where it's growing: The company already operates across Telangana, Andhra Pradesh, Tamil Nadu, Karnataka, and Maharashtra. "The capital will enable us to accelerate clinic expansion, strengthen our infrastructure, broaden our service offerings and advance our Kolors 2.0 transformation," said Vijaya Krishna, managing director of Kolors Healthcare.
Why now? Piramal Alternatives, which has $1.6 billion under management, makes credit and structured investments in mid-market companies. Its recent deals include a 1.25 billion INR investment in auto parts maker JRG Automotive IndustriesDealroom has a profile for this one. Try Dealroom → in July and an exit from Biodeal PharmaceuticalsDealroom has a profile for this one. Try Dealroom → last month.
The signal: At $22.5 million, the debt round sits in the lower band of deals in our dataset — around the 33rd percentile by size. But the bet reflects growing investor appetite for India's preventive healthcare and wellness segment, where profitable, regionally entrenched players like Kolors offer credit funds a clearer path to returns. "Kolors has built a strong brand and differentiated presence in the rapidly evolving wellness and preventive healthcare segment," said Kalpesh Kikani, chief executive officer of Piramal Alternatives.
Read more: htsyndication.com
Image credit: Presidio of Monterey: DLIFLC & USAG
